- Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review2 days ago
- Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations3 days ago
- The endocannabinoid system as a therapeutic target in prodromal psychosis: From molecular mechanisms to clinical applications5 days ago
- The role of psychopharmacology and cognitive neuroscience in understanding the brain in the treatment of psychiatric disorders and neurological diseases for the benefit of society6 days ago
- “Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS6 days ago
- A Bayesian network meta-analysis of randomized controlled trials comparing the efficacy and safety of cholinergic modulators in schizophrenia6 days ago
- Psychedelic research – Going global6 days ago
- (-)-OSU6162 reduces freezing elicited by context-conditioned fear in rats1 week ago
- Exploring early add-on celecoxib treatment in OCD: Results from a preliminary randomized, double-blind, placebo-controlled trial1 week ago
- Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour1 week ago
- Statistical limitations of the claimed dose–response in “Dose–response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials”1 week ago
- Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: A randomized, double-blind, placebo-controlled clinical trial2 weeks ago
- Long-term neurocognitive side effects of MDMA in recreational ecstasy users following sustained abstinence: A systematic review and meta-analysis3 weeks ago
- Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling3 weeks ago
- Antidepressant initiation and the risk of treatment-emergent mania in children and adolescents with depression: A real-world cohort study4 weeks ago